Navigation Links
Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
Date:9/28/2011

NEW YORK, Sept. 28, 2011 /PRNewswire/ -- Visionsense Corp announces an unique milestone this week when the 3D camera was used in its 500th neurosurgical procedure with the VSii system.

Dr. Nelson M. Oyesiku (Al Lerner Chair and Vice-Chairman, Dept of Neurosurgery at Emory University and Professor of Neurosurgery and Medicine (Endocrinology)) performed a transsphenoidal resection of a pituitary adenoma in the morning of September 22nd, 2011 triggering this milestone accomplishment in the use of the 3D camera in transsphenoidal surgery.

Dr. Oyesiku commented, "The Visionsense system takes the best features of a 2D endoscope and a 3D surgical microscope and melds them into one instrument. The reason why 3 dimensional vision (stereopsis) is very important is, it provides an accurate rendition of the surgical field without image distortion, which is critical when  operating around and within critical  structures in the brain."

Alex Chanin, the CEO of Visionsense, stated that "Visionsense celebrated this important milestone on the road of 3D soon becoming the standard of care in visualization in the operating room."

About Visionsense Corp.

Founded 13 years ago, located in (New York, NY) with R&D subsidiary (Visionsense Ltd.)  based in Israel. Visionsense develops miniature, three-dimensional (3-D) stereoscopic visualizations solutions for minimally invasive surgery. The company's digital platform technology is based on a customized, miniature 3-D (3.3 millimeter microchip) camera combined with image processing software that digitally maps anatomical structures in the surgical field, allowing surgeons to see in three dimensions.

CONTACT:  Alex Chanin, +1-732-895-7710


'/>"/>
SOURCE Visionsense Corp
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... CHICAGO , March 27, 2017  A ... Educators (AADE) found that Medicare,s Competitive Bidding Program (CBP) ... diabetes testing supplies. The lack of choice forces beneficiaries ... can have dire health consequences. AADE,s ... reports by AADE and others pointing out the inherent ...
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD is pleased to announce ... shares for trading on the TSX Venture Exchange.  ... TSXV follows a year of significant achievements for Invictus-MD. ... successful test crops at AB Laboratories Inc. ("AB Labs"), ...
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... in their profession as their value increases in the healthcare workforce, according to ... such as job boards, career fairs, and candidate leads to healthcare employers of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Bacteria and fungi are probably not the first ... bad. In fact, including the right microorganisms in your diet can actually improve health outcomes. ... , This is the topic of a new peer-reviewed paper led by ...
(Date:3/27/2017)... ... March 27, 2017 , ... The respected dental team at ... teeth without the extensive time commitment and aesthetic disadvantages of traditional braces can ... A custom-designed series of virtually invisible aligners are created for each patient and ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who want ... their missing teeth can now have them placed by Dr. Manju Kejriwal, with or ... Cone Beam technology to increase the accuracy of each dental implant placement. The i-CAT ...
(Date:3/27/2017)... London UK (PRWEB) , ... March 27, 2017 ... ... agility and ability to gain site attention and engagement over the household brands ... educational webinar will discuss how partnering with the right outsourcing payments ...
Breaking Medicine News(10 mins):